| abstract |
A method of producing polyclonal antibodies specifically reactive with human tissue plasminogen activator protein by immunizing animals, characterized in that a polypeptide corresponding to the EG F-like domain of human tissue plasminogen activator is used for immunization, blood is drawn and antibodies are isolated. (62) Number of the application from which the division was made: 283060 (43) The application was announced: 01.07.1991 BUP 13/91 (45) The patent was granted: 31.08.1994 WUP 08/94 PL |